Capex / revenue moved 288 bp lower
Capex / revenue changed -288 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed -288 basis points from the comparable as-filed period.
Capital expenditure changed -24.8% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Gross profit changed +18.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +155.3% from the comparable as-filed period.
Operating income changed +154.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed +7345 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed +22.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -61.9% from the comparable as-filed period.
Gross margin changed -261 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +8.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.